Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer

Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy

(2014) Takuya Koie et al.   International Journal of Clinical Oncology

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

(2012) Peter Grimm et al.   BJU INTERNATIONAL

Radical Prostatectomy for High-risk Prostate Cancer Defined by Preoperative Criteria: Oncologic Follow-up in National Multicenter Study in 813 Patients and Assessment of Easy-to-use Prognostic Substratification

(2011) Guillaume Ploussard et al.   UROLOGY

Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy

(2010) Jochen Walz et al.   BJU INTERNATIONAL

Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: A phase II trial

(2009) William Y. Kim et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

What Are the Outcomes of Radical Prostatectomy for High-risk Prostate Cancer?

(2009) Stacy Loeb et al.   UROLOGY